Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Smiles48on Jan 18, 2015 9:33pm

176 Views

Post# 23333704

RE:RE:RE:First Berlin Report

Do you know any other penny stock with such a NPV?
the volume and 0.15 high that we just saw says there was a leak. 01 is trying to burry it. Where there,s smoke...
The other interesting part in the report is SBM,s product being better and more efficient then that of Johnson and Johnson,s patented product! You want to bet that the giant is lobbying hard at the US patent office to prevent SBM,s product from getting it,s well deserved recognition. The natural pressure will come from the success of the product in China.

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale